# OrthAlign

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orthalign

- Industry: Medical Devices & Equipment
- Headquarters: Aliso Viejo, US
- Website: www.orthalign.com
- Total disclosed funding: $43M
- Latest round: Series C (Nov 6, 2014)
- Investors on record: 5

## About

OrthAlign is a technology company specializing in computer-assisted surgical solutions that enhance the precision of joint replacement procedures for orthopedic surgeons and surgical facilities.OrthAlign was founded to develop innovative surgical technologies. The company is headquartered in Aliso Viejo, US. The latest funding round occurred in November 2014, where OrthAlign raised USD 15.19 mn in a Series C round from investors including Mutual Capital Partners and River Cities Capital Funds. To date, OrthAlign has completed five deals, with a current company valuation of USD 28.93 mn.OrthAlign specializes in computer-assisted surgical solutions, focusing on joint replacement procedures. Their core products include the Lantern® product line, which offers technologies for total hip arthroplasty, total knee arthroplasty, revision knee arthroplasty, and partial knee arthroplasty. These products are aimed at enhancing surgical precision and efficiency, primarily used by orthopedic surgeons and surgical facilities across North America, Europe, and select regions in Asia.OrthAlign generates revenue through direct sales of its surgical solutions, particularly the Lantern® technologies, to healthcare providers, including orthopedic surgeons and surgical centers. These transactions often include training and support services to facilitate effective implementation. Revenue may also come from partnership agreements with healthcare institutions for product support and updates, reflecting a mixture of one-time equipment sales and ongoing service agreements.Looking ahead, OrthAlign aims to leverage its recent funding of USD 15.19 mn from the Series C round in November 2014 to enhance product development and expand its market presence. The company is designing new products to improve surgical outcomes and plans to enter new markets, specifically targeting regions in Asia and Europe by 2025. Their strategy includes reinforcing partnerships with surgical facilities to ensure broader access to their advanced technologies.

## Funding rounds

- Series C, Nov 6, 2014, $15M — RC Capital, Mutual Capital Partners
- Series C, Nov 6, 2014, $15M — RC Capital, Mutual Capital Partners
- Series A, Jan 26, 2010, $5.2M — California Technology Ventures, Research Corporation Technologies, Okapi Venture Capital
- Series A, Jan 7, 2009, $7.2M — Research Corporation Technologies, Okapi Venture Capital

## Investors

- Research Corporation Technologies (https://capitalatlas.ai/funds/research-corporation-technologies) — Series A
- Okapi Venture Capital (https://capitalatlas.ai/funds/okapi-venture-capital) — Series A
- California Technology Ventures (https://capitalatlas.ai/funds/california-technology-ventures) — Series A
- RC Capital (https://capitalatlas.ai/funds/rc-capital) — Series C
- Mutual Capital Partners (https://capitalatlas.ai/funds/mutual-capital-partners) — Series C